SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin of $6.85M in Q1 FY2026

Q1 FY2026 selling, general & admin was $6.85M.

What to watch

Whether selling, general & admin reaches the consensus estimate of $0 (-100.0%) for the fiscal year ending Dec 2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.85M+15.7% QoQ
Last fiscal yearDec 2025
$12.2M— YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year—-100.0%—
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
12.2M USD
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Selling, General & Admin for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$3.64B USD+8.6%+4.0%33.3%
BLCOBausch + Lomb CorporationLTM Jun 2026$2.22B USD+1.8%+14.8%41.8%
GKOSGlaukos CorporationLTM Jun 2026$386.7M USD+34.7%+19.5%63.1%
STAASTAAR Surgical CompanyLTM Apr 2026$177.31M USD-11.1%+9.5%61.1%
OCULOcular Therapeutix, Inc.LTM Mar 2026$124.38M USD+14.7%+17.9%239.0%
RXSTRxSight, Inc.LTM Mar 2026$115.87M USD+8.5%+24.3%90.9%
SGHTSight Sciences, Inc.LTM Mar 2026$91.48M USD-7.4%-9.4%115.0%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$53.04M USD+1.3%-5.0%696.5%
OCSOculis Holding AGLTM Mar 2026CHF 27.55M CHF+39.2%+54.0%5466.6%
SGPSpyGlass Pharma, Inc. Common StockFY2025$12.2M USD———
Peer median (excluding SGP) —+8.5%+14.8%90.9%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.